VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Information Disclosure
Information Disclosure
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Close Filter
Find report
Search
11/03/2023
IMP - Meeting invitation and documents for the 2024 General Meeting of Shareholders
11/03/2023
IMP - Resolution of the BOD on collecting written opinions of the GMS dated November 3, 2023
11/02/2023
IMP - Meeting invitation and documents for the 2024 General Meeting of Shareholders
10/27/2023
IMP - Meeting invitation and documents for the 2024 General Meeting of Shareholders
10/13/2023
IMP - Information disclosure: No. 499 Report on the results of the share issuance to pay dividends in 2022
10/13/2023
IMP - Disclosure: No. 500 Notice of change in number of shares with voting rights
09/22/2023
IMP-CBTT: HOSE announces the record date for paying dividends in 2022 in cash and IMP shares
09/20/2023
IMP - Disclosure: Regarding the record date and confirmation of the list of Securities owners.
09/15/2023
IMP - Resolution of the BOD No.9/2023/NQ-HĐQT-IMP dated September 15, 2023
09/15/2023
IMP: No 442/IMP on 15/09/2023 Re. the record date to excercise the right to receive dividends od 2023 byt cash and stocks
«
‹
5
6
7
8
9
10
11
12
13
14
15
›
»